Isavuconazole
Triazole and Tetrazole Derivatives
Sold as CRESEMBA
- Drug class
- Triazole and Tetrazole Derivatives
- Availability
- See label
- Routes
- Oral, Intravenous
- Markets covered
- 2
- Products on record
- 4
Overview
Isavuconazole is an active pharmaceutical ingredient in the Triazole and Tetrazole Derivatives group (J02AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 3 | July 22, 2025 |
| EU European Union | EMA | 1 | July 24, 2025 |
CACanada· Health Canada
3 products
Uses
11/2024 4 DOSAGE AND ADMINISTRATION 11/2024 7 WARNINGS AND PRECAUTIONS, Sensitivity/Resistance 04/2022 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ............................................................................................
2 TABLE OF CONTENTS .............................................................................................................. 2 PART I: HEALTH PROFESSIONAL INFORMATION ......................................................................
4 1 INDICATIONS ............................................................................................................... 4 2 CONTRAINDICATIONS .................................................................................................
4 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ............................................................ 5 4 DOSAGE AND ADMINISTRATION ................................................................................. 9 5 OVERDOSAGE..............................................................................................................
EUEuropean Union· EMA
1 product
Uses
1) Consideration should be given to official guidance on the appropriate use of antifungal agents.
How to take
Sources & citations
- [1]Health Canada (DPD) · 02483971 · revised July 22, 2025
- [2]European Medicines Agency · EMEA/H/C/002734 · revised July 24, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.